Varex Imaging (NASDAQ:VREX) Stock Rating Lowered by Zacks Research

Varex Imaging (NASDAQ:VREX) was downgraded by research analysts at Zacks Research from a “strong-buy” rating to a “hold” rating in a research note issued on Monday,Zacks.com reports.

Several other equities research analysts have also issued reports on the stock. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Varex Imaging in a report on Wednesday, June 24th. Wall Street Zen raised shares of Varex Imaging from a “hold” rating to a “buy” rating in a research note on Saturday, July 4th. Two investment analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus price target of $16.17.

Varex Imaging Price Performance

Varex Imaging stock opened at $11.13 on Monday. The company has a debt-to-equity ratio of 0.67, a quick ratio of 1.43 and a current ratio of 3.20. Varex Imaging has a 52 week low of $6.76 and a 52 week high of $14.56. The stock has a market capitalization of $468.57 million, a P/E ratio of -5.57 and a beta of 0.90. The stock has a fifty day moving average of $10.51 and a 200-day moving average of $11.61.

Varex Imaging (NASDAQ:VREX) last released its earnings results on Thursday, May 7th. The company reported $0.21 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.22 by ($0.01). The business had revenue of $216.00 million during the quarter, compared to the consensus estimate of $216.92 million. Varex Imaging had a negative net margin of 9.64% and a positive return on equity of 8.19%. Varex Imaging has set its Q3 2026 guidance at 0.150-0.300 EPS. On average, sell-side analysts expect that Varex Imaging will post 0.93 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Varex Imaging

Hedge funds have recently modified their holdings of the business. Vanguard Group Inc. raised its position in Varex Imaging by 4.4% during the 3rd quarter. Vanguard Group Inc. now owns 2,989,847 shares of the company’s stock worth $37,074,000 after purchasing an additional 126,396 shares during the last quarter. Cooke & Bieler LP lifted its stake in shares of Varex Imaging by 2.2% in the fourth quarter. Cooke & Bieler LP now owns 1,632,525 shares of the company’s stock worth $19,019,000 after acquiring an additional 35,042 shares during the period. Rice Hall James & Associates LLC boosted its holdings in Varex Imaging by 17.7% in the first quarter. Rice Hall James & Associates LLC now owns 1,274,818 shares of the company’s stock valued at $13,526,000 after acquiring an additional 191,854 shares during the last quarter. LSV Asset Management increased its position in Varex Imaging by 210.7% during the 4th quarter. LSV Asset Management now owns 1,244,329 shares of the company’s stock valued at $14,496,000 after purchasing an additional 843,805 shares during the period. Finally, Millennium Management LLC raised its holdings in Varex Imaging by 119.8% during the 3rd quarter. Millennium Management LLC now owns 913,169 shares of the company’s stock worth $11,323,000 after purchasing an additional 497,650 shares during the last quarter.

Varex Imaging Company Profile

Varex Imaging Corporation is a global provider of X-ray imaging components and solutions for the medical, security and industrial markets. The company designs, develops and manufactures a broad range of products that convert X-ray energy into high-resolution digital images. Its portfolio includes X-ray tubes, flat panel detectors, digital sensors, specialty radiographic tubes and related software, all engineered to meet the demanding requirements of original equipment manufacturers (OEMs) in diagnostic imaging, computed tomography (CT), fluoroscopy, mammography, dental radiography and non-destructive testing applications.

The company’s medical imaging offerings support a wide spectrum of clinical modalities, from portable radiography systems to advanced CT scanners, enhancing image quality and dose efficiency for healthcare providers.